Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A

Epigenetics has emerged as a prime focus area in the field of cancer research. Lysine-specific demethylase 1A (LSD1), the first discovered histone demethylase, is mainly responsible for catalysing demethylation of histone 3 lysine 4 (H3K4) and H3K9 to activate or inhibit gene transcription. LSD1 is...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Chao Yang (Författare, medförfattare), Dan Li (Författare, medförfattare), Shaohong Zang (Författare, medförfattare), Lei Zhang (Författare, medförfattare), Zhangfeng Zhong (Författare, medförfattare), Yingtang Zhou (Författare, medförfattare)
Materialtyp: Bok
Publicerad: Frontiers Media S.A., 2022-07-01T00:00:00Z.
Ämnen:
Länkar:Connect to this object online.
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!
Beskrivning
Sammanfattning:Epigenetics has emerged as a prime focus area in the field of cancer research. Lysine-specific demethylase 1A (LSD1), the first discovered histone demethylase, is mainly responsible for catalysing demethylation of histone 3 lysine 4 (H3K4) and H3K9 to activate or inhibit gene transcription. LSD1 is abnormally expressed in various cancers and participates in cancer proliferation, apoptosis, metastasis, invasion, drug resistance and other processes by interacting with regulatory factors. Therefore, it may serve as a potential therapeutic target for cancer. This review summarises the major oncogenic mechanisms mediated by LSD1 and provides a reference for developing novel and efficient anticancer strategies targeting LSD1.
Beskrivning:1663-9812
10.3389/fphar.2022.955218